Abstract:Genome sequencing (GS) provides exciting opportunities to rapidly identify a diagnosis in critically ill newborns and children with rare genetic conditions. Nevertheless, there are reasons to remain cautious about the use of GS. Studies to date have been mostly in highly selected populations of babies with unusual clinical presentations. GS leads to diagnoses in many such infants. More rarely, it leads to beneficial changes in management. Parents and physicians whose babies meet these criteria and for whom GS is performed both find these results useful. The concern is this: we do not know how useful such testing will be in the general population. We can speculate that a number of problems will arise as the use of GS expands. First, the percentage of cases in which a valid molecular diagnosis is made will likely go down. The number of ambiguous results or false positives will rise. Genetic counseling will become more complex and challenging. We do not know the relative cost-effectiveness of whole genome, whole exome, or targeted panels in different populations. We do not know the relative contribution of a molecular diagnosis to the decision to withdraw life support. We will have to carefully evaluate the use of such testing in order to understand whether it truly improves outcome and survival or reduces symptoms in babies who are tested. Each of these concerns will require careful study of both the technology and the ethical issues to allow us to harness the potential of these new technologies while avoiding foreseeable problems. Studies are underway to see how the tests are used in general populations. These studies should generate important information to guide clinicians and policymakers. As part of informed consent, doctors should explain to parents that genetic results are not always straightforward. Sometimes, they confirm a diagnosis that was already suspected. Sometimes, they rule out a possible diagnosis. Sometimes, the results are ambiguous and difficult to interpret. Anticipatory discussions should try to give parents a realistic understanding of the likely impact of a genetic diagnosis. Diagnostic genomic testing for newborns is a science that is still in its infancy. More research is essential in order to establish how to personalize this promising but sometimes problematic tool.

Hope, but never expect? Comparing parents' pre‐ and post‐disclosure attitudes toward return of results from diagnostic exome sequencing for their child

Comparison of medical management and genetic counseling options pre- and post-whole exome sequencing for patients with positive and negative results.

Parents' experiences with sequencing of all known pediatric cancer predisposition genes in children with cancer

Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)

Experts' Views on Children's Access to Community-Based Therapeutic and Education Services After Genomic Sequencing Results

Promises, pitfalls and practicalities of prenatal whole exome sequencing

A content analysis of parents' reflections on pathogenic and uncertain pediatric oncology germline sequencing results

Eliciting parental preferences and values for the return of additional findings from genomic sequencing

Exome sequencing in 90 children with developmental delay: a single-center experience

Parents' and patients' perspectives, experiences, and preferences for germline genetic or genomic testing of children with cancer: A systematic review

Views of children and young adults about Whole Genome Sequencing in newborn screening: a qualitative study

Experiences of pediatric cancer patients (age 12–18 years) with extensive germline sequencing for cancer predisposition: a qualitative study

'Something that helped the whole picture': Experiences of parents offered rapid prenatal exome sequencing in routine clinical care in the English National Health Service

Reverse Phenotyping after Whole-Exome Sequencing in Children with Developmental Delay/Intellectual Disability—An Exception or a Necessity?

Clinical use of whole exome sequencing in children with developmental delay/intellectual disability

Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq

The Future of Newborn Genomic Testing

Impact of a Genetic Diagnosis for a Child's Autism on Parental Perceptions

Parent's attitudes towards full-scale prenatal testing for genetic disorders

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Parent experiences with genetic testing for pediatric hearing loss